Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 201 to 225 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
960 increased Hepatic steatosis (HP:0001397) 459: Increase, Liver steatosis
959 increased Breast carcinoma (HP:0003002) BRCA1-A complex (GO:0070531) 1971: Increased, tumor growth
958 increased Breast carcinoma (HP:0003002) VEGF-A complex (GO:1990150) 1376: Increase, angiogenesis
957 occurrence transmission of virus (GO:0019089) 2194: Influenza A Virus (IAV) shedding and transmission
956 occurrence viral budding from plasma membrane (GO:0046761) 2193: Influenza A Virus (IAV) budding
955 occurrence modulation by virus of host immune response (GO:0075528) 2180: Immune mechanisms antagonized by viral proteins
954 occurrence virus induced gene silencing (GO:0009616) 2180: Immune mechanisms antagonized by viral proteins
953 occurrence suppression by virus of host cytokine production (GO:0046775) 2180: Immune mechanisms antagonized by viral proteins
952 occurrence virus maturation (GO:0019075) 2192: Influenza A Virus production increased
951 occurrence viral mRNA export from host cell nucleus (GO:0046784) 2192: Influenza A Virus production increased
950 occurrence nuclear export (GO:0051168) viral genome (GO:0019015) None
949 occurrence transcription, RNA-templated (GO:0001172) segmented viral genome (GO:0019017) 2192: Influenza A Virus production increased
948 occurrence protein import into nucleus (GO:0006606) viral RNA-directed RNA polymerase complex (GO:0031381) 2192: Influenza A Virus production increased
947 occurrence membrane fusion (GO:0061025) influenzavirus hemagglutinin (PR:000049750) None
946 occurrence pH reduction (GO:0045851) endosome (GO:0005768) None
945 occurrence vesicle targeting, plasma membrane to endosome (GO:0048201) None
944 occurrence clathrin-dependent endocytosis (GO:0072583) None
943 increased acute-phase response (GO:0006953) Acute phase proteins (N/A)
942 increased Atherosclerosis (HP:0002621) 1443: Atherosclerosis
941 increased acute-phase response (GO:0006953) None
940 decreased decreased body weight (MP:0001262) 864: Decreased, Body Weight
939 decreased sexual reproduction (GO:0019953) 2147: Decreased, Viable Offspring
938 decreased toll-like receptor 3 signaling pathway (GO:0034138) influenzavirus NS gene translation product (PR:000044794) 2180: Immune mechanisms antagonized by viral proteins
937 decreased toll-like receptor 7 signaling pathway (GO:0034154) influenzavirus NS gene translation product (PR:000044794) 2180: Immune mechanisms antagonized by viral proteins
936 decreased toll-like receptor 3 signaling pathway (GO:0034138) viral genome (GO:0019015) None